Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of cancer and has a poor
prognosis. Patients with PDAC are at high risk of developing thromboembolic events, which …

Simple Summary Cancer patients are at greater risk of developing venous
thromboembolism compared to the general population, which can lead to a decreased …

Opinion Statement Cancer-associated thrombosis (CAT) has been identified as the second
most prevalent cause of death after cancer itself. Moreover, the risk of thrombotic events in …

Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of all pancreatic
cancers and is the most fatal of all cancers. The treatment response from combination …

Simple Summary Preventing venous thromboembolic complications in patient with
gynecological cancers is a relevant issue and an unmet clinical need. Using a thorough …

Background Venous thromboembolism (VTE) is a leading cause of death in patients with
cancer. Limited data exist about VTE in patients with adrenocortical carcinoma (ACC). The …

The correlation between cancer and venous thromboembolism (VTE) is solid, whereas the
knowledge about cancer-related arterial thromboembolism (ATE) still needs a deeper …

Abstract Patients with chronic Myeloproliferative Neoplasms (MPN) including polycythemia
vera (PV) and essential thrombocythemia (ET) exhibit unique clinical features, such as a …

Venous thromboembolism (VTE) is a life-threatening haemostatic disease frequently
diagnosed among the cancer population. The Khorana Score is currently the primal risk …

Introduction Cancer-associated thrombosis (CAT) is a significant concern among patients
with malignant diseases, leading to increased mortality. While current guidelines …